SHU Yan. Application of platelet-rich plasma, Bio-Oss bone powder combined with Haiao biofilm in bone regeneration of oral implant in patients with diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 36-38. DOI: 10.7619/jcmp.202001009
Citation: SHU Yan. Application of platelet-rich plasma, Bio-Oss bone powder combined with Haiao biofilm in bone regeneration of oral implant in patients with diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 36-38. DOI: 10.7619/jcmp.202001009

Application of platelet-rich plasma, Bio-Oss bone powder combined with Haiao biofilm in bone regeneration of oral implant in patients with diabetes mellitus

More Information
  • Received Date: October 24, 2019
  • Available Online: December 22, 2020
  • Published Date: August 06, 2020
  • Objective To explore the application of platelet-rich plasma combined with Bio-Oss bone powder and Haiao biofilm in oral implant regeneration in diabetic patients. Methods A total of 80 diabetic patients with implant bone regeneration in our hospital were selected as study subjects, and were divided into control group and combined group by random number table method, with 40 cases in each group. The patients in the control group were treated with Bio-Oss bone powder and Haiao biofilm, and those in the combined group were treated with platelet-rich plasma combined with Bio-Oss bone powder and Haiao biofilm. The clinical efficacy, bone defect regeneration and complications of the two groups were compared and analyzed. Results The total effective rate of the combined group was 97.50%, which was significantly higher than 77.50% of the control group(P<0.05). The bleeding index, the depth of exploration, the loss of attachment, the height of bone graft and the thickness of osteogenesis were(0.36±0.08),(3.29±0.33)mm,(3.00±0.30)mm,(2.69±0.27)mm,(2.57±0.26)mm, respectively, in the combined group, which were significantly higher than those in the control group(P<0.05). The incidence of complications in the combined group was significantly lower than that in the control group(5.00% vs. 27.50%, P<0.05). Conclusion The application of platelet-rich plasma combined with Bio-Oss bone powder and Haiao biofilm in the treatment of dental implant bone regeneration in diabetic patients has a significant effect, which can significantly improve the bone defect regeneration, and reduce the incidence of complications.
  • 李勇, 程如玉, 彭学生, 等. 富自体浓缩生长因子联合Bio-Oss骨粉在颌骨囊肿中的疗效研究[J]. 中华全科医学, 2018, 16(7): 1113-1115.
    张璐, 王频, 郭玲, 等. 富自体浓缩生长因子纤维蛋白液在口腔骨缺损种植引导骨再生后的骨量变化[J]. 中国组织工程研究, 2017, 21(8): 1186-1191.
    董红宾, 张悦, 张琴, 等. PRF复合组织工程骨修复牙周骨缺损中基因的表达及意义[J]. 口腔医学, 2017, 37(11): 969-975.
    余伟, 向乐. 自体碎骨联合Bio-OSS骨粉应用于颌骨囊肿术后骨缺损中的临床效果[J]. 中国医药导报, 2017, 14(30): 129-131

    , 135.
    宋勇, 李想, 曹艳妮, 等. 基于Bio-Oss Geistlich的拔牙位点保存技术对牙槽骨吸收及短期美学疗效的影响[J]. 现代医学, 2017, 45(7): 965-969.
    王鸣照, 何家才. 两种不同骨替代材料在上颌前牙区种植体周围骨缺损中的应用效果评价[J]. 安徽医药, 2018, 22(3): 440-444.
    何浩, 徐梦婷, 肖强, 等. 富血小板纤维蛋白联合人工骨粉在口腔种植引导性骨再生中的临床应用价值[J]. 现代生物医学进展, 2019, 19(10): 1920-1923.
    高改霞. 富血小板血浆促进口腔种植骨再生的临床应用[J]. 血栓与止血学, 2019, 25(3): 457-458

    , 461.
    衣红梅, 薛洪权, 吴鸿, 等. 富含血小板纤维蛋白修复即刻种植体周围骨缺损的临床观察[J]. 现代口腔医学杂志, 2018, 32(1): 20-22.
    谢慧, 解永富, 刘勤, 等. 注射型富血小板纤维蛋白在上颌窦外提升术中的应用效果[J]. 上海口腔医学, 2019, 28(1): 71-75.
    董瑶, 董飞君, 潘凌峰. Bio-Oss骨粉联合富血小板纤维蛋白对口腔种植引导性骨再生术后黏膜愈合和骨缺损再生的影响研究[J]. 中国全科医学, 2017, 20(3): 162-164.
    申龙朵, 林炬, 李平, 等. 浓缩生长因子联合Bio-Oss骨粉在经牙槽嵴顶上颌窦提升术后种植中的应用[J]. 海南医学, 2018, 29(2): 253-255.
    陈景妍. 富血小板血浆引导骨再生在口腔种植中的应用与意义评定[J]. 名医, 2019(7): 27-27.
    顾珊, 贺海鹏, 李红文, 等. 富血小板血浆在口腔再生医学中的应用[J]. 赣南医学院学报, 2019, 39(8): 842-845

    , 860.
    贺于奇. 富血小板血浆复合材料修复纯钛金属体周骨缺损的动物实验[D]. 遵义: 遵义医学院, 2010.
    罗华渊, 牛晓珺. 富血小板血浆促进口腔种植骨再生的临床分析[J]. 医学理论与实践, 2015, 28(1): 85-86.
  • Related Articles

    [1]ZHU Rong, XIONG Zhaohui, CHEN Yunliang, LI Mengxin, WANG Haiquan. Effect of midazolam and dexmedetomidine in patients with septic shock during mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 124-127. DOI: 10.7619/jcmp.20223579
    [2]ZHU Guanneng, WANG Yang, SONG Haimiao, FENG Erwen. Analysis of risk factors and pathogenic bacteria of ventilator-associated pneumonia in patients with severe trauma undergoing mechanical ventilation in intensive care unit[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 101-104. DOI: 10.7619/jcmp.20214843
    [3]LU Jun, LIN Qian, ZHANG Dan, HU Hong. Effect of cluster nursing on ventilation time and nursing quality in mechanical ventilation neonates[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 53-55. DOI: 10.7619/jcmp.202007016
    [4]YANG Xuefeng. Effect of milrinone combined with high frequency ventilation on arterial blood gas index and mechanical ventilation time in neonates with persistent pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (11): 33-35,40. DOI: 10.7619/jcmp.201811009
    [5]TAO Yu. Cluster nursing intervention in prevention of ventilator-associated pneumonia in patients with mechanical ventilation in RICU[J]. Journal of Clinical Medicine in Practice, 2018, (6): 26-29. DOI: 10.7619/jcmp.201806008
    [6]WANG Miao. Effect of mechanical vibration sputum elimination in reducing pulmonary complications in ICU patients with mechanical ventilation after operation[J]. Journal of Clinical Medicine in Practice, 2017, (10): 70-73. DOI: 10.7619/jcmp.201710022
    [7]PAN Jingya, WAN Wenxia, LI Xuemei. Nursing of RICU patients with mechanically ventilated in sequential ventilation critical period[J]. Journal of Clinical Medicine in Practice, 2016, (22): 27-29. DOI: 10.7619/jcmp.201622009
    [8]ZHANG Hong, SHEN Yuhui, CEHN Huaming. The curative effect analysis of nursing intervention on the continuous respiratory mechanical ventilation in treatment for neonatal respiratory failure[J]. Journal of Clinical Medicine in Practice, 2015, (18): 101-104. DOI: 10.7619/jcmp.201518032
    [9]CHEN Haiwei, LIANG Peng, SU Ning, WEN Jianhua, SU Meihua. The value and the influencing factors of modified sputum-sucking method in prevention and treatment of ventilator-associated pneumonia in patients with mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2015, (14): 27-29,42. DOI: 10.7619/jcmp.201514009
    [10]XIE Youhua, LU Hong, HUANG Chunye. Nursing experience of mechanical ventilation in patients with replacement of mitral valve[J]. Journal of Clinical Medicine in Practice, 2013, (10): 49-51. DOI: 10.7619/jcmp.201310019
  • Cited by

    Periodical cited type(31)

    1. 黄奇峰,郑鹏程,戴燕玲. 二甲双胍、阿卡波糖分别联用厄贝沙坦治疗糖尿病合并高血压的临床效果比较. 糖尿病新世界. 2024(04): 56-59+66 .
    2. 孙燕,张新菊,李雁. 卡格列净在基层糖尿病慢病管理中的疗效观察. 兵团医学. 2024(01): 54-56 .
    3. 黄延峰,钟荣惠. 甘精胰岛素搭配阿卡波糖和二甲双胍对糖尿病控制和氧化应激的影响研究. 现代医学与健康研究电子杂志. 2024(12): 51-54 .
    4. 程继华,孟俊娜,雷巧玲. 艾塞那肽治疗2型糖尿病的疗效及对胰岛素抵抗与糖脂代谢的影响研究. 中国医学工程. 2024(08): 88-92 .
    5. 贾志壮. 阿卡波糖联合二甲双胍治疗2型糖尿病的效果. 名医. 2024(09): 165-167 .
    6. 黄伟玲. 阿卡波糖联合二甲双胍治疗2型糖尿病对免疫功能及不良反应的影响. 临床合理用药. 2024(28): 103-105+115 .
    7. 任喆. 阿卡波糖联合二甲双胍在社区糖尿病患者糖代谢控制中的应用效果. 中国社区医师. 2024(32): 26-28 .
    8. 张秀丽,余玉花,张文帝. 二甲双胍联合阿卡波糖对2型糖尿病患者免疫功能、糖脂代谢的影响. 糖尿病新世界. 2024(18): 86-88+92 .
    9. 林钧,陈玮,刘进清. 视网膜激光光凝术与阿卡波糖联合治疗糖尿病性黄斑水肿的临床疗效. 糖尿病新世界. 2024(23): 187-190 .
    10. 岳斌,张巍,徐丽,郑华东,李明. 二甲双胍联合阿卡波糖治疗2型糖尿病的疗效及对免疫功能和NLRP3水平的影响. 海南医学. 2023(01): 14-18 .
    11. 耿瑶. 探究达格列净治疗2型糖尿病并心衰的临床疗效及其对炎性因子、血管内皮功能的影响. 黑龙江医学. 2023(05): 547-550 .
    12. 王鑫. 阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效观察. 现代诊断与治疗. 2023(01): 64-66+69 .
    13. 卢洁菲. 阿卡波糖联合二甲双胍对2型糖尿病患者免疫功能及炎性因子的影响. 甘肃医药. 2023(04): 318-319+325 .
    14. 景珊. 二甲双胍联合阿卡波糖用于糖尿病治疗的疗效及对HbA1c、FPG水平的影响分析. 糖尿病新世界. 2023(09): 76-79 .
    15. 孙嘉婧,于湘英,马子良. 阿卡波糖与二甲双胍在社区糖尿病治疗中的效果及对血糖的影响探析. 糖尿病新世界. 2023(10): 108-111+115 .
    16. 卢凯丽,宋瑞捧,姜惠惠,高红红. 阿卡波糖联合维格列汀治疗初治2型糖尿病的效果及对糖脂代谢的影响. 中国实用医刊. 2023(14): 109-112 .
    17. 方信英. 二甲双胍联合阿卡波糖在2型糖尿病患者中的应用效果分析. 糖尿病新世界. 2023(23): 81-84 .
    18. 仲伟慧. 阿卡波糖联合二甲双胍治疗2型糖尿病的疗效分析. 中国社区医师. 2022(06): 76-77+80 .
    19. 刘燕君,朱明敏,陈亚东. 二甲双胍与预混胰岛素联用对2型糖尿病患者血糖指标水平与不良反应的影响. 糖尿病新世界. 2022(05): 68-71 .
    20. 刘婷,王莹,杨召娣,陈继芳. 阿卡波糖联合二甲双胍治疗2型糖尿病对患者血糖水平、胰岛功能的影响. 现代医学与健康研究电子杂志. 2022(12): 142-144 .
    21. 王云枫,王彦贺. 阿卡波糖对2型糖尿病患者血脂及尿酸代谢的影响. 哈尔滨医药. 2022(03): 62-63 .
    22. 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析. 糖尿病新世界. 2022(11): 102-105 .
    23. 陈聪,梁黎黎. 有氧-抗阻运动指导联合降糖药物对老年糖尿病患者的应用效果. 现代医学与健康研究电子杂志. 2022(21): 141-144 .
    24. 张建,范文文. DPP-4抑制剂联合阿卡波糖治疗初诊老年T2DM患者的疗效分析. 国际医药卫生导报. 2022(23): 3388-3391 .
    25. 黄文新. 瑞格列奈结合二甲双胍治疗2型糖尿病的疗效及对患者血糖水平的影响. 糖尿病新世界. 2021(07): 87-89 .
    26. 阳玲,黄冠军,方涛,柴振华,朱红艳. 二甲双胍联合阿格列汀或阿卡波糖治疗2型糖尿病的疗效对比. 药品评价. 2021(10): 621-623 .
    27. 徐露,章晓君. 阿卡波糖联合二甲双胍治疗糖尿病前期患者的效果分析. 现代医学与健康研究电子杂志. 2021(15): 51-53 .
    28. 房思思,屈桂茹. 拜糖平和二甲双胍治疗2型糖尿病的有效性及安全性研究. 中国药物滥用防治杂志. 2021(05): 682-684+703 .
    29. 周芸,刘路. 阿卡波糖联合二甲双胍对2型糖尿病患者血糖与肠促胰岛素水平的影响. 现代医学与健康研究电子杂志. 2021(18): 45-47 .
    30. 李黎,张瑞. 阿卡波糖联合二甲双胍用于治疗2型糖尿病临床效果分析. 世界复合医学. 2021(10): 195-198 .
    31. 宋先梅. 二甲双胍结合阿卡波糖治疗初发2型糖尿病伴高脂血症的临床效果分析. 中国现代药物应用. 2021(23): 139-141 .

    Other cited types(0)

Catalog

    Article views (441) PDF downloads (4) Cited by(31)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return